Biotech · Private company
Compugen Ltd
Track this companyFree. Adds Compugen Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- COM701Phase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- COM701 in combination with BMS-986207 and nivolumab.Phase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Cohort expansion: COM902 (RDFE) monotherapy.Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- Cohort expansion: COM902 in combination with COM701 (both at the RDFE).Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- Cohort expansion: Triplet combination of COM902 + COM701 + Pembrolizumab.Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- COM503Phase 1 · NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
- COM701Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- COM701 with Opdivo (Nivolumab).Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- Dose escalation: COM902 monotherapy.Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- Evaluation of safety/tolerability: COM902 in combination with COM701 (both at the RDFE)Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
- ZimberelimabPhase 1 · NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jul 21, 2025ClinicalTrials.gov NCT06888921 · fetched Nov 12, 2026
- A Clinical Trial to Assess COM503 in Participants With Advanced Solid MalignanciesPHASE1 · RECRUITING · started Jan 7, 2025ClinicalTrials.gov NCT06759649 · fetched Nov 12, 2026
- COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.PHASE1_PHASE2 · COMPLETED · started Aug 31, 2020ClinicalTrials.gov NCT04570839 · fetched Nov 12, 2026
- COM902 (A TIGIT Inhibitor) in Subjects With Advanced MalignanciesPHASE1 · COMPLETED · started Mar 31, 2020ClinicalTrials.gov NCT04354246 · fetched Nov 12, 2026
- COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.PHASE1 · COMPLETED · started Sep 6, 2018ClinicalTrials.gov NCT03667716 · fetched Nov 12, 2026